Delivery Order SPE2DB22D3011-SPE2DB26FP7KA
- Not listed
- The Defense Logistics Agency awarded a $29,013.01 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rifampin 150 mg capsules in quantities of 30 units. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a ceiling value of $1,137.07 and an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $1,069.22 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Rifampin 150 mg capsules (30-count unit). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a single delivery order under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a contract value of $15,777.11. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for ultimate completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Rifampin 300 mg capsules (30-count units) with a ceiling value of $1,789.57. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by July 15, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $13,755.84. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's pharmaceutical supply services under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Rifampin 300 mg capsules (60-count) with a contract ceiling value of $1,200.66. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made...
- The Defense Logistics Agency awarded a delivery order valued at $8,324.76 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on September 15, 2025, with completion targeted for September 16, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $4,160.15. This is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count) valued at $1,055.84 on November 4, 2025, with an ultimate completion date of November 5, 2025. This non-competitive, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB26FP7KADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $31,201.41. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The ultimate completion date for this delivery order is November 7, 2025, with performance to be executed from AmerisourceBergen's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order is one of numerous pharmaceutical supply orders the company fulfills through its DLA prime contract vehicle, which enables comprehensive global pharmaceutical support across multiple therapeutic domains including antibiotics, specialty medications, vaccines, and generic drugs. The company's federal contract portfolio demonstrates consistent capability to meet defense medical supply requirements through competitive procurement processes across a range of transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.2k | 11/6/25 |